Kidney transplant fast track and likelihood of waitlisting and transplant-A nonrandomized clinical trial

Kidney transplant fast track and likelihood of waitlisting and transplant-A nonrandomized clinical trial
JAMA Internal Medicine; by Larissa Myaskovsky, Yuridia Leyva, Chethan Puttarajappa, Arjun Kalaria, Yue-Harn Ng, Miriam Vélez-Bermúdez, Yiliang Zhu, Cindy Bryce, Emilee Croswell, Hannah Wesselman, Kellee Kendall, Chung-Chou Chang, L. Ebony Boulware, Amit Tevar, Mary Amanda Dew, 3/25
Although it is a seemingly intuitive solution to enabling more patients to complete the evaluation process and be added to the waitlist, to our knowledge, few transplant centers use a health care system–facilitated approach like KTFT [Kidney Transplant Fast Track]. In this nonrandomized clinical trial of 1,118 patients with end-stage kidney disease (ESKD) who underwent KTFT and a historical control group of 1,152 patients with ESKD undergoing evaluation for kidney transplant, the KTFT group had a higher likelihood of waitlisting and transplant than the historical control group. Unlike the historical control group, the KTFT group had no significant differences in kidney transplant by race or ethnicity.